{"bill":{"bill_id":1272041,"change_hash":"6c7a1d5b61c63d62344378134d62b326","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HCR55\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-concurrent-resolution\/55\/all-info","completed":0,"status":1,"status_date":"2019-07-24","progress":[{"date":"2019-07-24","event":1},{"date":"2019-07-24","event":9},{"date":"2019-07-24","event":9}],"state":"US","state_id":52,"bill_number":"HCR55","bill_type":"CR","bill_type_id":"3","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.","description":"This concurrent resolution expresses the sense of Congress that (1) the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; (2) the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; (3) the final rule by the CMS published in the Federal Register on May 10, 2019, makes substantial progress in improving drug pricing transparency; and (4) such rule should be enacted into law.","pending_committee_id":2302,"committee":{"committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},"referrals":[{"date":"2019-07-24","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"}],"history":[{"date":"2019-07-24","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2019-07-24","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-07-24","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":9176,"person_hash":"cu7fgqvh","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Michael Burgess","first_name":"Michael","middle_name":"C.","last_name":"Burgess","suffix":"","nickname":"","district":"HD-TX-26","ftm_eid":17658442,"votesmart_id":50120,"opensecrets_id":"N00025219","knowwho_pid":211708,"ballotpedia":"Michael_Burgess","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13156,"subject_name":"Department of Health and Human Services"},{"subject_id":13206,"subject_name":"Health care costs and insurance"},{"subject_id":13639,"subject_name":"Marketing and advertising"},{"subject_id":13239,"subject_name":"Medicaid"},{"subject_id":13242,"subject_name":"Medicare"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2047242,"date":"2019-07-25","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HCR55\/id\/2047242","state_link":"https:\/\/www.congress.gov\/116\/bills\/hconres55\/BILLS-116hconres55ih.pdf","text_size":361486,"text_hash":"4dddc0820050cf9908ea35a6f33c7ee3"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}